Dalton Investments LLC Novo Nordisk A S Transaction History
Dalton Investments LLC
- $154 Million
- Q4 2024
A detailed history of Dalton Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dalton Investments LLC holds 11,300 shares of NVO stock, worth $879,931. This represents 0.63% of its overall portfolio holdings.
Number of Shares
11,300
Previous 9,100
24.18%
Holding current value
$879,931
Previous $1.08 Million
10.25%
% of portfolio
0.63%
Previous 0.66%
Shares
2 transactions
Others Institutions Holding NVO
# of Institutions
1,873Shares Held
336MCall Options Held
9.21MPut Options Held
8.57M-
Jennison Associates LLC19.9MShares$1.55 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.21 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.01 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$984 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$950 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $176B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...